ArticleBrain : a journal of neurology2026

GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

Aleksandra Maleska Maceski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.